PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $990,044 | -23.1% | 32,270 | +0.4% | 0.00% | -20.0% |
Q2 2023 | $1,287,489 | +202.2% | 32,131 | +301.5% | 0.01% | +150.0% |
Q3 2022 | $426,000 | -8.8% | 8,002 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $467,000 | -40.5% | 8,002 | -22.2% | 0.00% | -33.3% |
Q1 2022 | $785,000 | +36.5% | 10,281 | +7.7% | 0.00% | +50.0% |
Q4 2021 | $575,000 | +7.1% | 9,550 | -0.5% | 0.00% | 0.0% |
Q3 2021 | $537,000 | -11.7% | 9,597 | -4.2% | 0.00% | -33.3% |
Q2 2021 | $608,000 | -34.7% | 10,022 | -24.5% | 0.00% | -25.0% |
Q1 2021 | $931,000 | -35.3% | 13,277 | -44.8% | 0.00% | -33.3% |
Q4 2020 | $1,440,000 | +0.7% | 24,068 | +1.2% | 0.01% | -14.3% |
Q3 2020 | $1,430,000 | -39.2% | 23,793 | -46.9% | 0.01% | -36.4% |
Q2 2020 | $2,353,000 | +58.1% | 44,847 | +1.1% | 0.01% | +22.2% |
Q1 2020 | $1,488,000 | +608.6% | 44,364 | +856.3% | 0.01% | +800.0% |
Q4 2019 | $210,000 | -50.8% | 4,639 | -58.6% | 0.00% | -50.0% |
Q3 2019 | $427,000 | -52.2% | 11,215 | -45.5% | 0.00% | -60.0% |
Q2 2019 | $894,000 | -4.6% | 20,560 | -16.5% | 0.01% | 0.0% |
Q1 2019 | $937,000 | +73.5% | 24,620 | +96.0% | 0.01% | +66.7% |
Q4 2018 | $540,000 | +9.8% | 12,560 | +25.4% | 0.00% | 0.0% |
Q3 2018 | $492,000 | +57.7% | 10,015 | +2.8% | 0.00% | +50.0% |
Q2 2018 | $312,000 | +43.8% | 9,745 | +217.9% | 0.00% | 0.0% |
Q2 2015 | $217,000 | – | 3,065 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |